Company / Goodwill
ImmunityBio, Inc. Goodwill History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$910.0K
FY2025
5-year range
$910.0K / $910.0K
FY2024-FY2025
Trend
+0.0%
vs FY2024
Sector context
#72 of 75
Health Care
What the data says
Among 75 Health Care companies, ImmunityBio, Inc. is in the bottom 4% for goodwill.
Based on SEC 10-K filings.
$910,000 in FY2025.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 75This company $910.0K Sector average $4.0B
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, goodwill increased 0.0% year-over-year.
- Ranks #72 out of 75 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $910.0K | +0.0% |
| FY2024 | $910.0K | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026